loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Technical details about GLPG1690, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 1628260-79-6, Glpg-1690, Glpg1690, 2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile, Ziritaxestat [usan], Glpg-1690(ziritaxestat)
Molecular Formula
C30H33FN8O2S
Molecular Weight
588.7  g/mol
InChI Key
REQQVBGILUTQNN-UHFFFAOYSA-N
FDA UNII
I02418V13W

Ziritaxestat is under investigation in clinical trial NCT03798366 (A Clinical Study to Test How Effective and Safe GLPG1690 is for Patients With Systemic Sclerosis).
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)-1,3-thiazole-5-carbonitrile
2.1.2 InChI
InChI=1S/C30H33FN8O2S/c1-4-24-29(35(3)30-34-27(25(14-32)42-30)20-5-7-21(31)8-6-20)39-15-22(13-19(2)28(39)33-24)37-11-9-36(10-12-37)18-26(41)38-16-23(40)17-38/h5-8,13,15,23,40H,4,9-12,16-18H2,1-3H3
2.1.3 InChI Key
REQQVBGILUTQNN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCC1=C(N2C=C(C=C(C2=N1)C)N3CCN(CC3)CC(=O)N4CC(C4)O)N(C)C5=NC(=C(S5)C#N)C6=CC=C(C=C6)F
2.2 Other Identifiers
2.2.1 UNII
I02418V13W
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo(1,2-a)pyridin-3-yl)methylamino)-4-(4-fluorophenyl)thiazole-5-carbonitrile

2. Glpg1690

2.3.2 Depositor-Supplied Synonyms

1. 1628260-79-6

2. Glpg-1690

3. Glpg1690

4. 2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile

5. Ziritaxestat [usan]

6. Glpg-1690(ziritaxestat)

7. Chembl3828074

8. G451990

9. I02418v13w

10. G-451990

11. 2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)-1,3-thiazole-5-carbonitrile

12. 5-thiazolecarbonitrile, 2-((2-ethyl-6-(4-(2-(3-hydroxy-1-azetidinyl)-2-oxoethyl)-1-piperazinyl)-8-methylimidazo(1,2-a)pyridin-3-yl)methylamino)-4-(4-fluorophenyl)-

13. Ziritaxestatn

14. Ziritaxestat (usan/inn)

15. Ziritaxestat [inn]

16. Ziritaxestat (glpg1690)

17. Gtpl9561

18. Schembl16051264

19. Unii-i02418v13w

20. Bcp20895

21. Ex-a1646

22. Bdbm50187686

23. Mfcd31544330

24. S8895

25. Who 11017

26. Cs-7634

27. Db15403

28. Sb19736

29. Compound 11 [pmid: 28414242]

30. Ac-36149

31. Hy-101772

32. J3.652.431f

33. D11844

34. A902613

35. Q23075652

36. 2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile;glpg1690

37. 42-ethyl-14-fluoro-83-hydroxy-3,48-dimethyl-7-oxo-3-aza-4(3,6)-imidazo(1,2-a)pyridina-5(1,4)-piperazina-2(4,2)-(1,3)thiazola-8(1)-azetidina-1(1)-benzenaoctaphane-25-carbonitrile

2.4 Create Date
2015-02-13
3 Chemical and Physical Properties
Molecular Weight 588.7 g/mol
Molecular Formula C30H33FN8O2S
XLogP34.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count10
Rotatable Bond Count7
Exact Mass588.24312166 g/mol
Monoisotopic Mass588.24312166 g/mol
Topological Polar Surface Area133 Ų
Heavy Atom Count42
Formal Charge0
Complexity995
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Post Enquiry
POST ENQUIRY